Earum Pharmaceuticals Ltd - Announcement Regarding Opportunity Of Withdrawal For Application Subscribed By Eligible Equity Shareholders / RE Holders
Download 
|
< Back |
| 05 Jun 2023 | |
| Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to bring to the attention of the investors that there is misprint on page no 40 under the heading of Minimum Subscription in letter of offer dated April 19, 2023, the misprinting is in regards to the applicability of Minimum Subscription, which states that the requirement of minimum subscription in the Issue shall be applicable. Further, we wish to state that same is not applicable as we are satisfying both the conditions a. if object of the issue involves financing other than financing of capital expenditure for a project and b. our Promoter Mr. Bhumishth Patel, vide letter dated 24th January, 2023 has given intend to fully subscribe to their portion of rights entitlement not renounce their rights except to the extent of renunciation within the promoter group. Accordingly, in terms of Regulation 86(2) of the SEBI ICDR Regulations, is not applicable to the Issue. | |
| View all announcements for Earum Pharmaceuticals Ltd | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback